Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models-Reference-Cited by-同舟云学术

Superior immune reconstitution using Treg-expanded donor cells versus PTCy treatment in preclinical HSCT models

Published:2018-10-18 Issue:20 Volume:3 Page:
ISSN:2379-3708
Container-title:JCI Insight
language:en
Short-container-title:

Author:

Wolf Dietlinde^ORCID,Bader Cameron S.^ORCID,Barreras Henry,Copsel Sabrina^ORCID,Pfeiffer Brent J.,Lightbourn Casey O.,Altman Norman H.,Komanduri Krishna V.^ORCID,Levy Robert B.

Funder

NIH

Kalish Family Foundation

Sylvester Cancer Center

NIH, Kalish Family Foundation, Sylvester Cancer Center

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Link

https://insight.jci.org/articles/view/121717/files/pdf

Reference61 articles.

1. Acute graft-versus-host disease: Pathophysiology, clinical manifestations, and management

2. Pathophysiology of Chronic Graft-versus-Host Disease and Therapeutic Targets

3. Acute Graft-versus-Host Disease — Biologic Process, Prevention, and Therapy

4. High-dose, post-transplantation cyclophosphamide to promote graft-host tolerance after allogeneic hematopoietic stem cell transplantation

5. Post-Transplantation Cyclophosphamide for Tolerance Induction in HLA-Haploidentical Bone Marrow Transplantation

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autoimmune Limbic Encephalitis in Patients with Hematologic Malignancies after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide;Cells;2023-08-11

2. Regulatory T Cell Amelioration of Graft-versus-Host Disease following Allogeneic/Xenogeneic Hematopoietic Stem Cell Transplantation Using Mobilized Mouse and Human Peripheral Blood Donors;Transplantation and Cellular Therapy;2023-05

3. Regulatory T-cell therapy approaches;Clinical and Experimental Immunology;2022-08-12

4. Donor genetic determinant of thymopoiesis rs2204985 impacts clinical outcome after single HLA mismatched hematopoietic stem cell transplantation;Bone Marrow Transplantation;2022-07-08

5. Improved NK Cell Recovery Following Use of PTCy or Treg Expanded Donors in Experimental MHC-Matched Allogeneic HSCT;Transplantation and Cellular Therapy;2022-06